Page 2 - Transvaginal Mesh in the Management of SUI: Addressing the Concerns
P. 2
Presenter Disclosures
KEVIN CARLSON Company/
Organization
I am a member of an Advisory Board or Astellas, Pfizer, Boston
equivalent with a commercial organization. Scientific
I have received payment from a commercial Astellas
organization (including gifts or other
consideration or ‘in kind’ compensation).
I have received a grant(s) or an honorarium from Astellas, Pfizer
a commercial organization.
I am currently participating in or have participated
in a clinical trial within the past two years.
BLAYNE WELK Company/
Organization
I am currently participating in or have participated Viveve
in a clinical trial within the past two years.